Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 06/30 03:40:55 pm
38.59 USD   +0.05%
06/23 ABBOTT LABORATO : Covered Call reports for Apple, SolarCity, Skywork..
06/22 ABBOTT : Hosts Conference Call for Second-Quarter Earnings
06/13 ABBOTT LABORATO : Announces Positive Results from Groundbreaking Stu..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales21 84820 24720 40520 90522 13023 418
Operating income (EBITDA)4 9745 8624 8505 0295 4685 876
Operating profit (EBIT)4 0464 3143 9794 0054 4574 772
Pre-Tax Profit (EBT)2 521-----
Net income2 5762 2844 4232 4183 3163 531
P/E ratio23,730,215,421,016,315,0
EPS ( $ )1,621,492,921,842,362,56
Dividend per Share ( $ )0,640,900,981,041,141,23
Yield1,67%2,00%2,18%2,69%2,94%3,19%
Reference price ( $ )38.3345.0244.9138.5738.5738.57
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt3 0863 7822 8763 4153 2642 649
Finance------
Operating income (EBITDA)4 9745 8624 8505 0295 4685 876
Leverage
(Debt/EBITDA)
0,62x0,65x0,59x0,68x0,60x0,45x
Capital Expenditure1 1451 0771 1101 1161 1661 262
Book Value Per Share (BVPS)16,3 $14,3 $14,4 $13,4 $16,3 $17,4 $
Cash Flow per Share2,11 $2,41 $1,97 $2,63 $3,35 $3,74 $
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 56 665 M$ -
Entreprise Value (EV) 60 080 M$ 59 929 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 21,0x 16,3x
Capitalization / Revenue 2,71x 2,56x
EV / Revenue 2,87x 2,71x
EV / EBITDA 11,9x 11,0x
Yield (DPS / Price) 2,69% 2,94%
Price to book (Price / BVPS) 2,89x 2,37x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,2% 20,1%
operating Leverage (Delta EBIT / Delta Sales) 0,27x 1,92x
Net Margin (Net Profit / Revenue) 11,6% 15,0%
ROA (Net Profit / Asset) 7,55% 9,04%
ROE (Net Profit / Equities) 15,6% 16,5%
Rate of Dividend 56,5% 48,1%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   5,34% 5,27%
Cash Flow / Sales 18,5% 22,3%
Capital Intensity (Assets / Sales) 1,53x 1,66x
Financial Leverage (Net Debt / EBITDA) 0,68x 0,60x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend